Syngulon
Desconocido
BREAKthrough: Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria throu...
Syngulon
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2021-DN-01
Antimicrobial resistance, which is caused by multi-drug-resistant bacterial pathogens is a global health emergency. Gram-negative bacteria (...
2022-07-14 - 2026-12-31 | Financiado
2022-07-14 - 2026-12-31 | Financiado
ALFF: The Algal Microbiome Friends and Foes
Syngulon
participó en un
H2020:
H2020-MSCA-ITN-2014
Algal aquaculture is developing exponentially worldwide, with multiple applications in the food, chemical and pharmaceutical industries. Cur...
2014-12-17 - 2018-12-31 | Financiado
2014-12-17 - 2018-12-31 | Financiado
* No se disponen de datos de la empresa actual.